Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The Effect of Glyceraldehyde-Derived Advanced Glycation End Products on β-Tubulin-Inhibited Neurite Outgrowth in SH-SY5Y Human Neuroblastoma Cells

27 Sept 2020

Abstract excerpt

Nutritional factors can affect the risk of developing neurological disorders and their rate of progression. In particular, abnormalities of carbohydrate metabolism in diabetes mellitus patients lead to an increased risk of neurological disorders such as Alzheimer's disease (AD). In this study, we investigated the relationship between nervous system disorder and the pathogenesis of AD by exposing SH-SY5Y...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Advanced Glycation End Products research
Share to Alzheimer's disease research and treatments
Share to Natural Antidiabetic Agents Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 32992566
DOI: 10.3390/nu12102958

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The Effect of Glyceraldehyde-Derived Advanced Glycation End Products on β-Tubulin-Inhibited Neurite Outgrowth in SH-SY5Y Human Neuroblastoma CellsPMID 32992566Read ↗

Glyceraldehyde caused Alzheimer’s disease-like alterations in diagnostic marker levels in SH-SY5Y human neuroblastoma cellsSemantic proximity Read ↗

Multifactorial Therapeutic Strategies Targeting Advanced Glycation End-Products, Oxidative Stress, and Metabolic Dysfunction in Alzheimer's DiseaseSemantic proximity Read ↗

Methylglyoxal reduces mitochondrial potential and activates Bax and caspase-3 in neurons: Implications for Alzheimer's disease.Semantic proximity Read ↗

Proteomics analysis of methylglyoxal‐induced neurotoxic effects in SH‐SY5Y cellsSemantic proximity Read ↗

Dessert or Poison? The Roles of Glycosylation in Alzheimer's, Parkinson's, Huntington's Disease, and Amyotrophic Lateral SclerosisSemantic proximity Read ↗

Hyper-Glycosylation as a Central Metabolic Driver of Alzheimer’s DiseaseSemantic proximity Read ↗

P301 L, an FTDP-17 Mutant, Exhibits Enhanced Glycation in vitro.Semantic proximity Read ↗

An aggregate-prone mutant of human glyceraldehyde-3-phosphate dehydrogenase augments oxidative stress-induced cell death in SH-SY5Y cells.Semantic proximity Read ↗

Glycation potentiates neurodegeneration in models of Huntington's disease.Semantic proximity Read ↗

Phenotyping of tianma-stimulated differentiated rat neuronal b104 cells by quantitative proteomics.Semantic proximity Read ↗

Acute Methylglyoxal-Induced Damage In Blood-Brain Barrier And Hippocampal TissueSemantic proximity Read ↗

Antiglycation effects of imidazole dipeptides and 2-oxo-imidazole dipeptides on glyceraldehyde-induced intracellular protein glycation and neuronal cell deathSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.